Literature DB >> 19110637

Canine models of gene-modified hematopoiesis.

Brian C Beard1, Hans-Peter Kiem.   

Abstract

Large animal models have played a crucial role in the development of gene therapy protocols. A significant advantage of large animal models over rodent models includes the ability to more easily translate protocols developed in large animals to humans. For gene therapy applications, nonhuman primates and canines have been the main large animal models. Canines have the advantage that there are disease models available, e.g., hemolytic anemia (pyruvate kinase deficiency), leukocyte adhesion deficiency, severe combined immunodeficiency (XSCID), storage diseases, and others. In addition, all three major integrating virus systems, i.e., gammaretrovirus-, HIV-derived lenti- and foamy virus vectors are able to efficiently transduce canine hematopoietic cells. Here we describe protocols developed for efficient transduction of canine hematopoietic repopulating cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19110637     DOI: 10.1007/978-1-59745-409-4_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Large animal models of hematopoietic stem cell gene therapy.

Authors:  G D Trobridge; H-P Kiem
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

Review 2.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.

Authors:  Chuanfeng Wu; Cynthia E Dunbar
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

3.  A novel acute anemia model for pharmacological research in mice by compelled acute exercise.

Authors:  Qing-shan Liu; Jin-hua Wang; Jian Cui; Zhi-hong Yang; Guan-hua Du
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

4.  In vivo protection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate.

Authors:  Jennifer L Gori; Brian C Beard; Nathaniel P Williams; Christina Ironside; Debra Swanson; R Scott McIvor; Hans-Peter Kiem
Journal:  J Gene Med       Date:  2013 Jun-Jul       Impact factor: 4.565

5.  Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Javier Torres-Torronteras; Raquel Cabrera-Pérez; Ignasi Barba; Carme Costa; Noemí de Luna; Antoni L Andreu; Jordi Barquinero; Michio Hirano; Yolanda Cámara; Ramon Martí
Journal:  Hum Gene Ther       Date:  2016-05-04       Impact factor: 5.695

6.  Reprogramming homing endonuclease specificity through computational design and directed evolution.

Authors:  Summer B Thyme; Sandrine J S Boissel; S Arshiya Quadri; Tony Nolan; Dean A Baker; Rachel U Park; Lara Kusak; Justin Ashworth; David Baker
Journal:  Nucleic Acids Res       Date:  2013-11-21       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.